BRAINSTORM CELL THERAPEUTICS INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2024.
  • Brainstorm Cell Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$2.97M, a 46.7% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$11.6M, a 32.4% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$11.6M, a 32.4% increase from 2023.
  • Brainstorm Cell Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$17.2M, a 29.2% increase from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$24.3M, a 0.74% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$11.6M -$2.97M +$2.61M +46.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$14.2M -$2.71M -$1.48M -121% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$12.7M -$2.54M +$2.79M +52.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$15.5M -$3.4M +$1.66M +32.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$17.2M -$5.58M -$560K -11.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$16.6M -$1.23M +$5.63M +82.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$22.3M -$5.33M +$1.71M +24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$24M -$5.06M +$301K +5.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$24.3M -$5.02M +$1.17M +18.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$25.4M -$6.86M -$1.52M -28.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$23.9M -$7.04M -$772K -12.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$23.2M -$5.36M +$1.3M +19.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$24.5M -$6.19M +$5.63M +47.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$30.1M -$5.34M -$848K -18.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29.2M -$6.27M +$1.13M +15.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$30.4M -$6.66M +$1.45M +17.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$31.8M -$11.8M -$4.12M -53.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$27.7M -$4.49M +$1.15M +20.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$28.8M -$7.39M -$2.49M -50.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$26.3M -$8.11M -$3.09M -61.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$23.3M -$7.69M -$2.31M -42.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 -$20.9M -$5.63M -$2.46M -77.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-15
Q2 2019 -$18.5M -$4.9M -$1.81M -58.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-10-15
Q1 2019 -$16.7M -$5.03M -$2.73M -119% Jan 1, 2019 Mar 31, 2019 10-Q 2020-10-15
Q4 2018 -$13.9M -$5.38M -$5.66M -2050% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 -$8.29M -$3.18M -$773K -32.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$7.52M -$3.09M -$2.05M -197% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.47M -$2.3M -$513K -28.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$4.95M $276K +$900K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$5.85M -$2.4M -$797K -49.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$5.06M -$1.04M -$78K -8.11% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 -$4.98M -$1.79M +$5K +0.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$4.98M -$624K +$760K +54.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$5.74M -$1.61M +$997K +38.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-17
Q2 2016 -$6.74M -$962K +$1.3M +57.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$8.04M -$1.79M +$446K +19.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$8.49M -$1.38M +$1.35M +49.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$9.83M -$2.6M -$182K -7.52% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$9.65M -$2.27M -$281K -14.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$9.37M -$2.24M -$125K -5.92% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$9.25M -$2.73M -$1.51M -124% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$7.73M -$2.42M -$1.34M -124% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$6.39M -$1.98M -$466K -30.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$5.93M -$2.11M -$1.03M -95.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$4.9M -$1.22M -$639K -111% Oct 1, 2013 Dec 31, 2013 10-Q 2015-08-13
Q3 2013 -$4.26M -$1.08M +$68K +5.91% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$4.33M -$1.52M -$688K -82.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.64M -$1.08M -$210K -24.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$3.43M -$578K +$3.04M +84% Oct 1, 2012 Dec 31, 2012 10-Q 2014-05-13
Q3 2012 -$6.47M -$1.15M -$456K -65.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$6.01M -$830K -$1.93M -176% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.09M -$872K -$167K -23.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$3.92M -$3.62M Oct 1, 2011 Dec 31, 2011 10-Q 2014-05-13
Q3 2011 -$694K -$1.4M -199% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $1.1M +$483K +78.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-29
Q1 2011 -$705K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $704K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $614K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.